Two Sigma Investments’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Two Sigma Investments’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-5,000	Closed	-$346K	–	3408
2024 Q1	$346K	Buy	+5,000	New	+$344K	﹤0.01%	2496

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

KIM

Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Two Sigma Investments's ITCI Position: Q2 2025 in Review

Two Sigma Investments sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 193,891 shares — an estimated $25.6M sold.

Two Sigma Investments first reported a position in ITCI in Q1 2015 and held it in 14 quarters. The position peaked at $25.6M in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

Two Sigma Investments reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
Two Sigma Investments sold 193,891 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $25.6M.
Two Sigma Investments first reported a position in Intra-Cellular Therapies Inc. in Q1 2015 and held it in 14 quarters.
Two Sigma Investments's Intra-Cellular Therapies Inc. position peaked at $25.6M in Q1 2025.
4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Two Sigma Investments's 13F filing for Q2 2025, filed 14 Aug 2025.